Literature DB >> 8179453

Treatment of infections in the patient with acquired immunodeficiency syndrome.

G H Smith1.   

Abstract

Modern technology has led to a contemporary medical practice that must be able to manage a variety of opportunistic infections in the immunocompromised host. The most common causes of immune suppression are immunosuppressive therapy after organ transplantation, granulocytopenia secondary to cancer chemotherapy, and the human immunodeficiency virus (HIV). All of these forms of immunosuppression predispose patients to a wide variety of opportunistic infections caused by reduction in T- and B-cell lymphocyte function as well as depression of neutrophils. However, the acquired immunodeficiency syndrome (AIDS) has presented the clinician with the greatest challenge in this area. Therefore, it is imperative that physicians and other health care professionals have a comprehensive understanding of the recommended therapy as well as the epidemiology, pathogenesis, and diagnosis of the various infections in these patients.

Entities:  

Mesh:

Year:  1994        PMID: 8179453

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

Review 1.  Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.

Authors:  M Pirmohamed; S Madden; B K Park
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

2.  Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity.

Authors:  D J Naisbitt; S J Hough; H J Gill; M Pirmohamed; N R Kitteringham; B K Park
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

3.  Functional adrenal insufficiency among critically ill patients with human immunodeficiency virus in a resource-limited setting.

Authors:  David B Meya; Elly Katabira; Marcel Otim; Allan Ronald; Robert Colebunders; Denise Njama; Harriet Mayanja-Kizza; Christopher C Whalen; Merle Sande
Journal:  Afr Health Sci       Date:  2007-06       Impact factor: 0.927

Review 4.  Atovaquone. A review of its pharmacological properties and therapeutic efficacy in opportunistic infections.

Authors:  C M Spencer; K L Goa
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.